-
Potential applications of dopamine D1 agonist and D2 antagonist LEK-8829Živin, Marko, 1958-Ergoline derivative 9,10-Didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829), possesses dopamine (DA) D1 agonistic and D2 antagonistic properties in the ... nigrostriatal and mesocorticolimbic DAergic pathways. These unique dual effects have suggested that LEK-8829 could effectively restore previously imbalanced functional linkage between D1 and D2receptors under schizophrenic conditions in which, LEK-8829 could improve both the negative and positive symptoms of schizophrenia. As dopamine D1 receptor agonist, LEK-8829 may also be beneficial in relieving the motor symptoms of parkinsonism, alone, or when co-administered with antiparkinsonic dopamine D2 agonists, such as ergoline derivative bromocriptine. Moreover, antiparkinsonic potential of LEK-8829 may be particularly useful when the treatment of parkinsonism with D2 agonist drugs is complicated by psychosis. Antiparkinsonic properties of LEK-8829 also suggest a lower propensity of the drug for the induction of extrapyramidal syndrome in the treatment of schizophrenia. Furthermore, by blocking dopamine D2 receptors, LEK-8829 could block the incentive for drug-seeking and drug-craving while by stimulating dopamine D1 receptors it could mediate drug reward and gratification. This implies that LEK-8829 could also attenuate the relapse of psychostimulant drug-addiction, while not being addictive by itself. We conclude that agents with LEK-8829-like dual actions toward dopamine receptors, may represent a newand potent drug class for the treatment parkinsonism, schizophrenia and drug-addiction.Source: Slovenian veterinary research = Slovenski veterinarski zbornik : the scientific journal of the Veterinary Faculty University of Ljubljana. - ISSN 1580-4003 (Letn. 47, št. 4, 2010, str. 175-180)Type of material - article, component partPublish date - 2010Language - englishCOBISS.SI-ID - 27799513
Author
Živin, Marko, 1958-
Topics
Ergolines |
Analogs And Derivatives |
Dopamine Agonists |
Dopamine Antagonists |
Receptors, Dopamine D1 |
Receptors, Dopamine D2 |
Schizophrenia |
Drug Therapy |
Parkinson Disease |
Drug Therapy |
Gene Expression |
Rats |
Dopaminski agonisti |
Receptorji dopaminski D2 |
Ergolini |
Dopaminski antagonisti |
Receptorji dopaminski D1 |
Parkinsonova bolezen |
Gensko izražanje |
Shizofrenija |
Podgane
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
| Year | Impact factor | Edition | Category | Classification | ||||
|---|---|---|---|---|---|---|---|---|
| JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
Impact factor
Select the library membership card:
DRS, in which the journal is indexed
| Database name | Field | Year |
|---|
| Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
|---|---|
| Živin, Marko, 1958- | 08289 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
| Pickup location | Material status | Reservation |
|---|
Please wait a moment.